Skip to content
MarketScale
‹ Back to IndustriesSciences

The Infrastructure Available to the Commercial Space Industry will Impact Affordability of Launches

Peter Beck launched Rocket Lab in 2006 in New Zealand. Though his background isn’t traditional, he knew he wanted to build rickets from a young age. He quickly developed international partnerships and expanded with venture capitalists in 2014. Since 2014, the company has doubled in size every year. Today, Rocket Lab has more than a…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Chris Blackerby · Peter BeckRocket LabSpace ExplorationSpace Sustainability
Share

Key takeaways

01

Peter Beck launched Rocket Lab in 2006 in New Zealand.

02

Though his background isn’t traditional, he knew he wanted to build rickets from a young age.

03

He quickly developed international partnerships and expanded with venture capitalists in 2014.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Start free

Peter Beck launched Rocket Lab in 2006 in New Zealand. Though his background isn’t traditional, he knew he wanted to build rickets from a young age. He quickly developed international partnerships and expanded with venture capitalists in 2014. Since 2014, the company has doubled in size every year. Today, Rocket Lab has more than a thousand employees. Beck said, “we made quite a few acquisitions last year, and we doubled that way.”

Rocket Lab requires the best of the best from its partners, and some of those partnerships have led to acquisitions. After long held relationships, Beck recognized the best in class and grew the Rocket Lab family. With US Headquarters and operating in New Zealand and a couple of other countries, Beck said, “we’ve been global since day one and we’re used to operating in various hemispheres.”

In addition to expecting the best in class, Rocket Lab prioritizes sustainability. The launch company is exploring ways to make their rockets more sustainable, both by decreasing the stage times of the rockets and by transitioning elements into working satellites while in orbit. Beck knows that the entire industry has to adapt to become more sustainable. “There’s technology to sustain space, but it’s better not to get there in the first place,” said Beck.

History of space exploration has accumulated dead rockets in orbit. Leaving the upper stages with huge mass in orbit, “is not cool,” said Beck. According to the Committee on the Peaceful Uses of Outer Space, “the Earth’s orbital space environment constitutes a finite resource that is being used by an increasing number of States, international intergovernmental organizations and non-governmental entities.” Hence, the focus on transformative elements so that Rocket Lab vehicles can lead the industry in responsible launching.

The majority of the work for sustainability has to be done by governments and authorities. “As a launch provider we’re a glorified freight company,” said Beck. It’s a logistical nightmare for regulation to fall onto the freight company. “There’s not cohesive framework there, there has to be a global regulation.” According to the Secure World Foundation, space sustainability requires international cooperation, discussion and agreements designed to ensure that outer space is safe, secure, and peaceful. Addressing increasing complexity of space operations requires international cooperation.

More in This Series

This Season’s Mission Will Be Making Space Relatable

The Impact of the Russian ASAT Tests

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

CB
Chris Blackerby
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Sciences Insights

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

CDMOs’ new capacity skews stainless by liters, but single-use leads by system count

Contract Pharma reports bioTRAK data projecting CDMOs will install roughly 120 bioreactors by 2030. It says 71% of added volume is large-scale stainless steel, while 61% of systems are single-use.

  • 01Utilization discipline is still driving builds: BioTRAK’s Dawn Ecker told Contract Pharma expansion conversations typically start after a site is booked above ~80% for several years.

Sep 22, 2026

Pharma supplier diversification means little if every supplier uses the same airport

Pharma supplier diversification means little if every supplier uses the same airport

Biocair's Patrick Wohl argues in Pharmaceutical Commerce that life sciences firms must map airports, sea lanes, customs gateways and carriers alongside suppliers. Suppliers spread across countries can still share one air hub. The fix he describes is pre-qualified alternate routes and continuous review, with clinical trial shipments and cold-chain medicines the first cargo exposed when a corridor closes.

  • 01A supplier base spread across several countries can still be a single point of failure if every shipment routes through one airport hub or corridor; the sharper question for a logistics provider is which hubs each qualified lane actually depends on.
  • 02Gartner data cited by MD+DI gives a benchmark: 42% of procurement leaders rank supply disruption as their organization's top risk, with geopolitical issues including tariffs and regulatory changes ranking third.
  • 03A route map ages fast. Pharmaceutical Commerce published the mapping argument on July 24 and was reporting fresh Red Sea and Iran-related freight risk for pharma lanes by Aug. 10, which is the case for treating mapping as a recurring review rather than a project.

Sep 17, 2026

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

Resilience and Eli Lilly are investing $750 million to expand KwikPen injectable device production at Resilience's Cincinnati-region manufacturing facility, expected to create 400 high-skilled jobs and reach full operations by early 2027. The partnership builds on their collaboration since 2023, which has already produced over 150 million doses of Lilly medications for the U.S. market.

  • 01$750 million investment to expand Resilience's Ohio manufacturing capacity for Eli Lilly's KwikPen injectable device production
  • 02400 new high-skilled jobs expected in Cincinnati region, with full operations by early 2027
  • 03Partnership has already produced over 150 million doses of Lilly medications for the U.S. market since 2023

Sep 14, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

CB
Chris Blackerby

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512